Breaking News Instant updates and real-time market news.

VRX

Valeant

07:03
06/08/16
06/08
07:03
06/08/16
07:03

Saying 'things can always get worse,' Wells cuts Valeant price target

Wells Fargo analyst David Maris lowered his estimates for Valeant Pharmaceuticals following the company's Q1 results and cut his price target range for the shares to $17-$22 from $25-$30. The embattled drugmaker closed yesterday down 14% to $24.67 after cutting its outlook for 2016. "Sometimes something is so complex and so persistently negative that people become fatigued by it," leading to stock buying on the belief that things can't get worse, Maris tells investors in a post-earnings research note. "Things can always get worse," he reminds investors. Maris believes this is the case for Valeant. "There was really nothing in the quarter that was a bright spot," he argues. Further, the analyst believes Valeant may face "significant challenges" to meet its debt obligations in 2020. He keeps an Underperform rating on the shares.

  • 10

    Jun

  • 14

    Jun

  • 19

    Jul

  • 16

    Nov

VRX Valeant

05/27/16
PIPR
05/27/16
NO CHANGE
PIPR
Underweight
Valeant takeover rejection report 'difficult to fathom,' says Piper Jaffray
Piper Jaffray analyst David Amsellem noted the report claiming that Valeant (VRX) previously rejected a takeover offer from Takeda (TKPYY) and TPG prior to appointing Joe Papa as CEO, but said he finds it "difficult to fathom" why a buyer would have interest in the entire asset portfolio, since he believes the value of its segments to be "meaningfully" below the company's $31B in total debt outstanding. Amsellem, who thinks there would be significant strategic interest in Valeant's gastroenterology assets, believes that any strategic activity will come in the form of asset sales or a breakup of the company. The firm keeps an Underweight rating on Valeant shares.
06/03/16
ADAM
06/03/16
NO CHANGE
Target $40
ADAM
Hold
Valeant challenges remain and work to be done, says Canaccord
Canaccord analyst Neil Maruoka previewed Q1 results for Valeant (VRX) scheduled for June 7th. The analyst expects many of the issues from last year to spill into the first quarter including lost sales from Philidor, potential challenges with the implementation of the Walgreens (WBA) distribution agreement, and pricing headwinds. Maruoka remains cautious ahead of likely Q1 results and the potential for lowered guidance and so maintains his Hold rating and $40 price target on Valeant shares.
06/07/16
WELS
06/07/16
NO CHANGE
WELS
Underperform
Valeant performing 'significantly worse than expected,' says Wells Fargo
Wells Fargo analyst David Maris says his preliminary look at Valeant's Q1 results indicate the company is performing "significantly worse than expected." Despite the SEC's correspondence with Valeant over the past several months over not prominently focusing on adjusted non-GAAP measures, Valeant only provided non-GAAP earnings guidance, Maris tells investors in a post-earnings research note. "We are uncertain as to why Valeant continues not to provide GAAP earnings forecasts for investors," Maris writes. He believes the company will be challenged to make its debt payments through 2020 if the business stays the way it is. The Walgreens (WBA) program "seems uninspiring," Maris adds. The analyst keeps an Underperform rating on Valeant with a $25-$30 price target range. The stock is down 16%, or $4.58, to $24.26 in pre-market trading with the company's earnings conference call ongoing.
06/08/16
JPMS
06/08/16
NO CHANGE
Target $50
JPMS
Overweight
Valeant price target lowered to $50 from $60 at JPMorgan
JPMorgan analyst Chris Schott lowered his price target for Valeant Pharmaceuticals to $50 from $60 following the drugmaker's Q1 results. The stock closed yesterday down 14%, or $4.18, to $24.67. After meeting with management following yesterday's results, Schott views Valeant's reduced guidance as achievable and is encouraged by the steps new CEO Joe Papa is taking to stabilize the business. He expects, however, a "long road to recovery" as the company works to reestablish credibility. Schott keeps an Overweight rating on Valeant.

TODAY'S FREE FLY STORIES

BABA

Alibaba

$159.50

1.75 (1.11%)

, WMT

Wal-Mart

$80.98

0.21 (0.26%)

20:25
08/16/17
08/16
20:25
08/16/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

BABA

Alibaba

$159.50

1.75 (1.11%)

WMT

Wal-Mart

$80.98

0.21 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 17

    Aug

  • 17

    Aug

  • 18

    Aug

  • 16

    Nov

  • 20

    Feb

ATU

Actuant

$22.90

-0.2 (-0.87%)

19:22
08/16/17
08/16
19:22
08/16/17
19:22
Hot Stocks
Actuant agrees to divest Viking SeaTech, acquire Mirage Machines »

Actuant Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVO

Novo Nordisk

$46.41

0.9 (1.98%)

19:17
08/16/17
08/16
19:17
08/16/17
19:17
Hot Stocks
Novo Nordisk: SUSTAIN 7 results show superior reduction in HbA1c »

Novo Nordisk announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

GOOG

Alphabet

$926.96

4.74 (0.51%)

, GOOGL

Alphabet Class A

$944.27

6.19 (0.66%)

18:48
08/16/17
08/16
18:48
08/16/17
18:48
Periodicals
Google acquires AIMatter, TechCrunch reports »

Google has acquired…

GOOG

Alphabet

$926.96

4.74 (0.51%)

GOOGL

Alphabet Class A

$944.27

6.19 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 18

    Aug

  • 24

    Aug

SRUN

Silver Run

$10.19

0.01 (0.10%)

18:37
08/16/17
08/16
18:37
08/16/17
18:37
Hot Stocks
Silver Run merging with Alta Mesa and Kingfisher Midstream into $3.8B company »

Silver Run Acquisition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEI

Heico

$85.55

-0.87 (-1.01%)

18:37
08/16/17
08/16
18:37
08/16/17
18:37
Downgrade
Heico rating change at Deutsche Bank »

Heico downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 07

    Sep

GPRK

GeoPark

$8.61

-0.13 (-1.49%)

18:36
08/16/17
08/16
18:36
08/16/17
18:36
Earnings
GeoPark reports Q2 revenue $75.2M, consensus $70.38M »

Reports Q2 consolidated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

MEDP

Medpace

$31.21

-0.16 (-0.51%)

18:14
08/16/17
08/16
18:14
08/16/17
18:14
Hot Stocks
Medpace announces stock repurchase agreement with Cinven »

Medpace Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

TOUR

Tuniu

$7.76

-0.18 (-2.27%)

18:04
08/16/17
08/16
18:04
08/16/17
18:04
Earnings
Tuniu reports Q2 EPS (11c), consensus (26c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

GLDD

Great Lakes Dredge

$3.85

-0.15 (-3.75%)

18:03
08/16/17
08/16
18:03
08/16/17
18:03
Hot Stocks
Great Lakes Dredge CEO acquires 42,610 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TISI

Team

$11.10

-0.25 (-2.20%)

18:00
08/16/17
08/16
18:00
08/16/17
18:00
Hot Stocks
Team director Lois Waters purchases 17,500 shares of company stock »

Team director Lois Waters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$42.41

0.44 (1.05%)

17:59
08/16/17
08/16
17:59
08/16/17
17:59
Hot Stocks
Breaking Hot Stocks news story on NetApp »

NetApp says expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

  • 14

    Sep

NTAP

NetApp

$42.41

0.44 (1.05%)

17:58
08/16/17
08/16
17:58
08/16/17
17:58
Hot Stocks
Breaking Hot Stocks news story on NetApp »

NetApp says expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

  • 14

    Sep

NTAP

NetApp

$42.42

0.44 (1.05%)

17:52
08/16/17
08/16
17:52
08/16/17
17:52
Earnings
NetApp sees low double digit EPS growth for FY18, consensus $3.03 »

Sees FY18 adjusted gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

  • 14

    Sep

SFST

Southern First Bancshares

$36.00

0.05 (0.14%)

17:50
08/16/17
08/16
17:50
08/16/17
17:50
Hot Stocks
Southern First Bancshares CFO Michael Dowling sells 5,850 shares »

Southern First Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

BXE

Bellatrix Exploration

$2.40

-0.03 (-1.23%)

17:49
08/16/17
08/16
17:49
08/16/17
17:49
Hot Stocks
Bellatrix Exploration regains NYSE minimum price compliance »

Bellatrix Exploration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$42.41

0.44 (1.05%)

17:48
08/16/17
08/16
17:48
08/16/17
17:48
Hot Stocks
NetApp says headwind for services revenue to decrease in coming quarters »

Comments from Q1 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 06

    Sep

  • 14

    Sep

ACHN

Achillion

$4.88

-0.12 (-2.40%)

17:45
08/16/17
08/16
17:45
08/16/17
17:45
Conference/Events
Achillion management to meet with William Blair »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

BCOR

Blucora

$23.35

0.1 (0.43%)

, BBOX

Black Box

$3.75

-0.25 (-6.25%)

17:35
08/16/17
08/16
17:35
08/16/17
17:35
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: Blucora (BCOR),…

BCOR

Blucora

$23.35

0.1 (0.43%)

BBOX

Black Box

$3.75

-0.25 (-6.25%)

BGG

Briggs & Stratton

$24.09

0.29 (1.22%)

LB

L Brands

$39.55

0.5 (1.28%)

VIPS

Vipshop

$11.10

-0.07 (-0.63%)

SPTN

SpartanNash

$25.96

0.07 (0.27%)

SNPS

Synopsys

$79.09

0.86 (1.10%)

CSCO

Cisco

$32.34

0.25 (0.78%)

NTAP

NetApp

$42.41

0.44 (1.05%)

LAKE

Lakeland Industries

$15.65

-0.25 (-1.57%)

GCP

GCP Applied Technologies

$28.75

0.1 (0.35%)

FNGN

Financial Engines

$34.35

-0.1 (-0.29%)

ACHC

Acadia

$51.68

-0.33 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

  • 16

    Aug

  • 16

    Aug

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

  • 29

    Aug

  • 06

    Sep

  • 06

    Sep

  • 06

    Sep

  • 14

    Sep

  • 30

    Nov

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

ANDX

Andeavor Logistics

$46.94

0.12 (0.26%)

, WNRL

Western Refining Logistics

$24.25

0.1 (0.41%)

17:26
08/16/17
08/16
17:26
08/16/17
17:26
Upgrade
Andeavor Logistics, Western Refining Logistics rating change at MUFG »

Andeavor Logistics…

ANDX

Andeavor Logistics

$46.94

0.12 (0.26%)

WNRL

Western Refining Logistics

$24.25

0.1 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$200.61

1.12 (0.56%)

17:22
08/16/17
08/16
17:22
08/16/17
17:22
Hot Stocks
General Dynamics awarded $115.3M government contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

BLVD

Boulevard Acquisition

$10.04

-0.01 (-0.10%)

17:17
08/16/17
08/16
17:17
08/16/17
17:17
Hot Stocks
Breaking Hot Stocks news story on Boulevard Acquisition »

Glazer Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMBH

First Mid-Illinois Bancshares

$34.85

-0.33 (-0.94%)

17:17
08/16/17
08/16
17:17
08/16/17
17:17
Syndicate
First Mid-Illinois Bancshares files to sell $20M of common stock 'at-the-market' »

First Mid-Illinois…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

NCOM

National Commerce

$39.55

0.1 (0.25%)

17:16
08/16/17
08/16
17:16
08/16/17
17:16
Hot Stocks
National Commerce, FirstAtlantic Financial sign definitive merger agreement »

National Commerce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

AMGN

Amgen

$171.39

1.35 (0.79%)

17:13
08/16/17
08/16
17:13
08/16/17
17:13
Hot Stocks
Amgen: NEJM publishes results from Repatha cognitive function trial »

Amgen announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 18

    Aug

  • 08

    Sep

  • 14

    Sep

  • 02

    Dec

  • 03

    Feb

  • 17

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.